BC Cancer is at the forefront of innovative research, harnessing state-of-the-art technology to advance breakthroughs in treatments and care for patients in Vancouver, the Lower Mainland and beyond.
Be a part of the progress. Connect with us today:
Enhancing BC Cancer – Vancouver’s technology infrastructure will revolutionize every stage of cancer care—improving diagnoses, treatments and research—while addressing the needs of a growing and aging population.
Key advancements will include:
BC Cancer’s provincial immunotherapy program is dedicated to developing the next generation CAR-T immunotherapies to target a wide range of cancers. CAR-T therapy uses genetically engineered T-cells from a patient’s own body to attack and destroy cancer cells.
BC Cancer is at the forefront of this groundbreaking field, advancing research through:
BC Cancer’s genomics program helps personalize treatments by understanding cancer’s unique genetic and environmental drivers – identifying patients who may not respond to standard treatments, redirecting them to more effective options.
Genomic breakthroughs are leading to new treatments across various cancer types:
BC Cancer is at the forefront of ground-breaking clinical trials and research. From award-winning COVID-19 research to landmark discoveries in ovarian and breast cancer, donor impact continues to fuel improved patient outcomes and providing new treatment options for all British Columbians.
Clinical Trials & Research Priorities:
The Collings Stevens Family Foundation generously donated $1 million to support critical research in Chronic Myeloid Leukemia.
Carol & Leigh Pan gave $1 million in 2019 to replace an aging PET/CT with a state-of-the-art scanner that has benefited countless patients.
Paul Balfour has been a huge supporter of The Tour de Cure, raising millions over the years.
“There’s been a revolution in new cancer therapies. We’re at a time where we can match the best treatment for each individual patient.”
Dr. Dan Renouf
Executive Medical Director, BC Cancer – Vancouver
